Sign in

GLIORESOLVE

@glioresolve.bsky.social
435 followers 359 following 66 posts

Horizon Europe MSCA Doctoral Network identifying a new tumour microenvironment-targeting platform for brain tumours. Find us at www.glioresolve.eu

PostsRepliesMedia
GLIORESOLVE @glioresolve.bsky.social · 27/09/2026
Good to see our doctoral candidate @soumi07.bsky.social presenting her work at #EANO2026! We hope the whole team from @institutducerveau.bsky.social had a great EANO meeting 🤗
011
Reposted by GLIORESOLVE
Paris Brain Institute - Institut du Cerveau @institutducerveau.bsky.social · 22/09/2026
📆 On 13 November 2026, from 8:30 a.m. to 6:30 p.m., the Paris Brain Institute will host the CLARA Symposium 2026 organised as part of the CLARA Days 2026. 👉 Information and registration: www.clara-center.eu/clara-symposium…
011
Reposted by GLIORESOLVE
EANO @eanoassociation.bsky.social · 21/07/2026
Have you registered for #EANO2026 yet? Join the global #NeuroOncology community in Rome, Italy, from September 24–27, 2026. The #EANO Board is looking forward to welcoming you for four days of outstanding science, collaboration, and networking. 🎟 Register at the regular rate until August 12.
033
GLIORESOLVE @glioresolve.bsky.social · 25/08/2026
Read an amazing work by Bellamy C and Bielle F on Chordoid glioma (ChG), a very rare brain tumour. How mutation alters the tumour microenvironment. Pseudokinase-converting mutation in protein kinase C alpha drives chordoid glioma by pathway rewiring-https://doi.org/10.1073/pnas.2524934123
011
GLIORESOLVE @glioresolve.bsky.social · 21/08/2026
@rcsi-research.bsky.social www.glioresolve.eu GLIORESOLVE Doctoral Candidate, Mohannad, presenting at the 2026 Irish Neuro-Oncology Society meeting in Dublin. Mohannad seeks to identify new 'precision medicine' options for high grade brain tumours 💊 Excellent talk and great progress in your work 👏
022
GLIORESOLVE @glioresolve.bsky.social · 04/08/2026
Starting a spatial project on the GBM microenvironment? New review walks through the spatial transcriptomic, proteomic & single-cell platforms applied to GBM patient samples over the past 5 years — plus the practical design choices behind them. 🔗 doi.org/10.3390/gene...
doi.org
010
GLIORESOLVE @glioresolve.bsky.social · 04/08/2026
GBM as network failure, not just a mass. 871 patients: preoperative DTI → whole-brain connectomes → graph metrics → ML. Random forest predicted >1y survival at AUROC 0.93, and 2/3 of the most informative nodes sat in the temporal lobe.
doi.org
000
GLIORESOLVE @glioresolve.bsky.social · 04/08/2026
Not just cell states — neighbourhoods. Nature Neuroscience integrated 121 spatial transcriptomics, scRNA-seq, scATAC & patch-seq profiles from 100 GBM patients → 4 malignant cellular communities that recur across tumours. #glioblastoma #spatialomics #compbio #neurooncology
nature.com
Spatial and single-cell characterization of human glioblastoma tumor microenvironment reveals malignant cellular communities - Nature Neuroscience
Integrating spatial and single-cell data from 100 patients, the authors define conserved cellular communities and communications in glioblastoma, revealing distinct mesenchymal-like tumor subtypes and...
010
GLIORESOLVE @glioresolve.bsky.social · 20/07/2026
The final GLIORESOLVE meeting took place recently👉 www.glioresolve.eu/new-blog-1/g... It was great to see everyone & hear the research updates. As the project concludes, we wish our DCs every success & hope their time with GLIORESOLVE will be a launchpad for exceptional careers in research & beyond🚀
141
GLIORESOLVE @glioresolve.bsky.social · 16/07/2026
Can sugar be our way in to curing glioblastoma? An interesting read.
021
GLIORESOLVE @glioresolve.bsky.social · 13/07/2026
medicalxpress.com/news/2026-07...
medicalxpress.com
First-in-human immunotherapy more than doubles progression-free survival in glioblastoma patients
Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most challenging cancers to treat because of limited treatment options and a poor prognosis. Patient outcomes have...
011
Reposted by GLIORESOLVE
Martine Lamfers @martinelamfers.bsky.social · 30/06/2026
Great final @glioresolve.bsky.social meeting at RCSI Dublin last week where doctoral candidates shared their glioblastoma research updates. New models, treatments, and insights bringing us closer to better therapies. A fantastic group of researchers to be part of. Looking forward to the next steps!
111
Reposted by GLIORESOLVE
Lukas Bunse @lukasbunse.bsky.social · 23/06/2026
Heading back from the fourth and last plenary Glioresolve @glioresolve.bsky.social Meeting from Dublin @rcsi.bsky.social! Terrific to see how our doctoral network students advance science in the field of glioblastoma and develop their careers - can’t wait to hear more from them in the future!
041
Reposted by GLIORESOLVE
Anna Golebiewska @annagolebiewska.bsky.social · 12/06/2026
Preclinical modeling of the tumor microenvironment remains a challenge in #glioblastoma! Check out what is possible with #organoids in our new review in Seminars in Cancer Biology: doi.org/10.1016/j.se..., #LIH, #FnrLux , #TELEVIE, #NET4BRAIN,
doi.org
Redirecting
054
GLIORESOLVE @glioresolve.bsky.social · 15/06/2026
Paris Neuro-Oncology Conference: Brain Tumors Across Ages 📩 Submit your abstract (500 words) before September 18, 2026 to: contactpnoc@gmail.com 🧳Travel grants for young researchers may be available upon request. Please contact the following email to submit an application: contactpnoc@gmail.com
121
Reposted by GLIORESOLVE
EANO @eanoassociation.bsky.social · 26/05/2026
📣 It’s today! Registration for #EANO2026 is now open. Join us in #Rome (IT), Sept 24–27, 2026, and connect with leading experts in #NeuroOncology. 🎟 Early Bird fees available until July 7, 2026. 👉 eano.eu/eano2026/reg... #Neurosurgery #Neuroradiology #Neurology #Oncology #PalliativeCare #Nursing
043
GLIORESOLVE @glioresolve.bsky.social · 03/06/2026
Translational data indicate that the PDGFRA/KIT inhibitor avapritinib shows preclinical activity and effective blood-brain barrier penetration in PDGFRA-altered high-grade glioma (HGG). Early clinical observations in a small cohort (n=8) showed a radiographic response in 3/7 cases.
cell.com
Effective targeting of PDGFRA-altered high-grade glioma with avapritinib
PDGFRA is commonly altered in pediatric HGG. Mayr et al. report that the PDGFRA/KIT inhibitor avapritinib demonstrates on-target activity, brain penetrance, and survival benefit in pre-clinical H3K27M...
021
Reposted by GLIORESOLVE
MIMETAS @mimetas.bsky.social · 30/04/2026
CAR T works in blood cancers, but solid tumors remain tough. Our tumor–vasculature-on-chip model lets you track T cell trafficking, infiltration & killing in 3D. Read our case study: shorturl.at/cgx31 #CARTcells #Immunotherapy
001
Reposted by GLIORESOLVE
Nature @nature.com · 08/04/2026
Nature research paper: Synthetic super-enhancers enable precision viral immunotherapy go.nature.com/4soUwPI
go.nature.com
Synthetic super-enhancers enable precision viral immunotherapy - Nature
Synthetic super-enhancers enable specific delivery of anticancer payloads, achieving tumour elimination after a single dose in a mouse model of aggressive glioblastoma.
0146
Reposted by GLIORESOLVE
Waggoner Lab @labwaggoner.bsky.social · 24/04/2026
Type I IFN drives T cell responses to amyloid beta in the central nervous system @natcomms.nature.com @lukasbunse.bsky.social www.nature.com/articles/s41...
052
GLIORESOLVE @glioresolve.bsky.social · 26/03/2026
A tech entrepreneur with no biology background just helped design a personalized mRNA cancer vaccine for his dog, Rosie. How? By teaming up with scientists and using ChatGPT and AlphaFold to analyze her tumor's sequenced DNA and identify neoantigens. 🧬🐕
210
GLIORESOLVE @glioresolve.bsky.social · 20/03/2026
📣Check out the latest publications from GLIORESOLVE labs www.glioresolve.eu/publications From tumour microenvironment insights to new therapeutic strategies... Perfect weekend reading 🧠 #glioma #cancerresearch 🔬 @annagolebiewska.bsky.social @linqianweng.bsky.social @bergerslab.bsky.social
glioresolve.eu
Publications — GLIORESOLVE
000
Reposted by GLIORESOLVE
Anna Golebiewska @annagolebiewska.bsky.social · 11/03/2026
How can brain tumor organoids advance research, drug efficacy studies, and precision medicine? Check out our new review in Nature Reviews Neurology. doi.org/10.1038/s415... @LIH_Luxembourg , @glioresolve.bsky.social, @FnrLux, #NET4BRAIN
doi.org
Modelling brain tumours with organoids: towards precision medicine in neuro-oncology - Nature Reviews Neurology
Organoids provide a useful model to capture the heterogeneity of brain tumours. Here, the authors assess current methodologies for generating organoids from various types of brain tumour and discuss h...
012
Reposted by GLIORESOLVE
Anna Golebiewska @annagolebiewska.bsky.social · 08/01/2026
Can immunotherapy ever work in #glioblastoma? In a new #NatureCancer review, we share our perspective on current limitations and future directions: www.nature.com/articles/s43... #NORLUX, #LIH , @fnr.lu #TELEVIE, @glioresolve.bsky.social, @michael-platten.bsky.social
nature.com
Immunosuppressive mechanisms and therapeutic interventions shaping glioblastoma immunity - Nature Cancer
In this Review, Golebiewska and colleagues summarize the main features of the immunosuppressive microenvironment in glioblastoma (GBM) and discuss how different therapeutic approaches reshape GBM immu...
2115
Reposted by GLIORESOLVE
EANO @eanoassociation.bsky.social · 04/02/2026
🎗️ On World Cancer Day, we stand united. #EANO brings together experts across disciplines and borders to advance research, education, and care in neuro-oncology. Together, we continue to shape the future of cancer care. 💙 👉 Learn more: www.eano.eu #WorldCancerDay #NeuroOncology #BrainTumors
021
GLIORESOLVE @glioresolve.bsky.social · 02/02/2026
New review on the immunology of brain tumors: dissecting tumor antigenicity, the immunosuppressive microenvironment, and strategies to empower T cell-mediated therapies in the brain. (PMID 41042911) pubmed.ncbi.nlm.nih.gov/41042911/
pubmed.ncbi.nlm.nih.gov
The immunology of brain tumors - PubMed
Brain tumors represent a unique challenge for cancer immunotherapies because of their location in an immune privileged site. However, the brain tumor immune microenvironment is dictated more by tumor type than the location within the brain per se. This feature is reflected by the higher immunogenici …
000
GLIORESOLVE @glioresolve.bsky.social · 02/02/2026
ComSciCon is a series of workshops focused on the communication of complex and technical concepts organized by graduate students, for graduate students- will now be organised from 7 to 10 July 2026 in Bordeaux. Deadline for registration is February 15 23:59 Link- france.comscicon.com/candidature/
france.comscicon.com
Je candidate ! - ComSciCon France
Candidatez à l'édition 2025 de ComSciCon France ! Les candidatures sont ouvertes aux doctorant·e·s de toutes disciplines !
000
Reposted by GLIORESOLVE
EANO @eanoassociation.bsky.social · 26/01/2026
𝙍𝙚𝙢𝙞𝙣𝙙𝙚𝙧: 𝙍𝙚𝙜𝙞𝙨𝙩𝙚𝙧 𝙛𝙤𝙧 𝙩𝙝𝙚 𝙀𝘼𝙉𝙊 𝙏𝙪𝙢𝙤𝙧 𝘽𝙤𝙖𝙧𝙙 𝟐𝟎𝟐𝟔 Following the successful first edition in Prague, the 2nd #EANOTumorBoard will take place on March 12, 2026, in Bucharest, RO, just before the #EANO Seminars. 🗓️ Registration deadline: February 23, 2026 www.eano.eu/eanomeetings...
024
Reposted by GLIORESOLVE
National Brain Tumor Society @braintumor.org · 26/01/2026
Join our Caregiver Support Conversation on Mon, Feb 2, at 7 PM ET to connect with fellow care partners who understand the challenges of supporting someone with a brain tumor. Share, listen & find community in a welcoming, safe space: braintumor.org/support-services/support-groups/caregiver-support
001
Reposted by GLIORESOLVE
National Brain Tumor Society @braintumor.org · 27/12/2025
NBTS is unlocking clinical trials & driving progress against #glioblastoma. In 2025, we ⭐ accelerated a Phase II trial for a promising #GBM vaccine ⭐ discovered a new vulnerability to launch a new clinical trial Give now to help us do even more in 2026: Braintumor.org/Impact
022
Reposted by GLIORESOLVE
Cancer Research UK Cambridge Centre @crukcamcentre.bsky.social · 19/12/2025
The NIHR have announced a £13.7m investment to establish a Consortium to transform outcomes for brain tumour patients in the UK. The Consortium will be co-led by Dr Richard Mair, one of our Brain Cancer Virtual Institute leads. Find out more: crukcambridgecentre.org.uk/NIHRBrainTum...
041
Reposted by GLIORESOLVE
Silvia Remeseiro Lab @remeseiro-lab.bsky.social · 14/11/2025
Excited to share I’ve received a #SSMF #Consolidator grant! 📣 Recruiting a #postdoc to study #cancer #neuroscience #3Dgenomics #multiomics #singlecellomics 🔬How neural inputs shape #3Dgenome and #cellplasticity in #glioblastoma #GBM Interested? Apply now 👇 rb.gy/m7xz7b
rb.gy
Postdoctoral Researcher in "Cancer Neuroscience: the impact of neural activity on 3D genome organization and cellular plasticity in glioblastoma”
52711
Reposted by GLIORESOLVE
Anna Golebiewska @annagolebiewska.bsky.social · 23/11/2025
Happy to share a new #NORLUX study on how humanized patient-derived xenografts of #glioblastoma can be useful in investigating immunosuppression and clinically-relevant immunotherapy testing. See for more: www.biorxiv.org/content/10.1... #immunotherapy, #preclinicalmodeling,
0154
Reposted by GLIORESOLVE
RCSI University of Medicine and Health Sciences @rcsi.bsky.social · 04/12/2025
RCSI welcomes the #ARCHubTherapeuticsLaunch, a €31.6m research initiative to fast-track biomedical innovation into real-world impact. RCSI will drive clinical and translational aspects of the Hub as a partner institution. 🔗 www.rcsi.com/dublin/news-... #RCSIdiscover #euinmyregion 🇮🇪🇪🇺
Three people stand side by side in front of a large presentation screen displaying the ARC Hub for Therapeutics logo and tagline, “Accelerating Research to Commercialisation.” The group includes one woman in a black jacket and pink trousers positioned between two men in smart casual attire. They are smiling towards the camera in a conference setting,
011
Reposted by GLIORESOLVE
Cell Press Events @cellpressevents.bsky.social · 02/12/2025
We're excited to host a distinguished lineup of speakers at @CellSymposia #CSHallmarks2026, including keynote speakers @johannajoyce.bsky.social & Faisal Mahmood @harvardmed.bsky.social. View the full speaker lineup: dlvr.it/TPbBqL
Cell Symposia: Hallmarks of cancer
065
GLIORESOLVE @glioresolve.bsky.social · 03/12/2025
🗺️Recently, 4 of our students have been based in @rcsi.bsky.social. Mohannad was joined by Promise @mimetas.bsky.social Soumi @soumi07.bsky.social @institutducerveau.bsky.social & Aleksandr #GeneXplain who were completing academic secondments. We hope that you all had a great time in Dublin!🙏
032
Reposted by GLIORESOLVE
Royal Irish Academy @ria.ie · 27/07/2025
We are honoured to welcome our new Member, Annette Byrne, professor of Physiology at the @rcsi.bsky.social and head of the RCSI Precision Cancer Medicine Group. Learn about #RIAAdmittanceDay 2025: www.ria.ie/2025/05/22/28-new-members-admitted-to-the-royal-irish-academy/
051
GLIORESOLVE @glioresolve.bsky.social · 03/12/2025
📣Read our 3rd newsletter & see what we have been up to recently! Find it here: www.glioresolve.eu/media-1 @institutducerveau.bsky.social @lih-luxembourg.bsky.social @erasmusmc.bsky.social @rcsi-research.bsky.social @uniheidelberg.bsky.social @viblifesciences.bsky.social @mimetas.bsky.social
032
GLIORESOLVE @glioresolve.bsky.social · 13/11/2025
🚨 Attention please! 🚨 The key dates for #EACR2026 are finally here — ✨ Abstract submission opens: 1 December 2025 ✨ Registration opens: 7 January 2026 Time to start preparing your research highlights, ideas — #EACR2026. A fantastic opportunity to connect with the global cancer research community. 🔬
2026.eacr.org
EACR 2026 Congress: Innovative Cancer Science | EACR2026
010
Reposted by GLIORESOLVE
EACR - European Association for Cancer Research @helloeacr.bsky.social · 13/11/2025
Join our free webinar with @10xgenomics.bsky.social! Camilla Engblom: spatially resolving antigen receptors in tumour tissue Heidi Haikala: ex vivo modelling of the tumour immune microenvironment in lung cancer 📅 04 Dec, 15:00 CET us02web.zoom.us/webinar/regi...
011
Reposted by GLIORESOLVE
EMBL-EBI Training @training.ebi.embl.org · 05/08/2025
Gain an introduction to the technology, data analysis, tools, and resources used in RNA sequencing and transcriptomics. Introduction to RNA-seq and functional interpretation will run virtually from 9 – 13 February 2026: www.ebi.ac.uk/training/eve... @ebi.embl.org @events.embl.org 🧬🖥️
Course at EMBL-EBI. Introduction to RNA-seq and functional interpretation. 9 – 13 February 2026. Virtual. EMBL's European Bioinformatics Institute logo.
021
Reposted by GLIORESOLVE
EMBL-EBI Training @training.ebi.embl.org · 23/10/2025
Reminder: applications close for our single-cell RNA-seq with Python course next week. Course dates: 2 – 6 February 2026 Course fee: from £240.00, funding is available. Location: virtual, UK time zone Apply by 2 November 2025: www.ebi.ac.uk/training/eve... #Python #SingleCell #Bioinformatics 🧬📊🐍
052
Reposted by GLIORESOLVE
Paris Brain Institute - Institut du Cerveau @institutducerveau.bsky.social · 10/11/2025
🧠 A recent Quanta Magazine article presents a new generation of researchers, including Thomas Andrillon and Nicolas Decat from Paris Brain Institute, exploring the subtle dynamics of consciousness between sleep and wakefulness. 👉 urlr.me/8kgGq4
urlr.me
How the Brain Moves From Waking Life to Sleep (and Back Again) | Quanta Magazine
Neuroscientists probing the boundary between sleep and awareness are finding many types of liminal states, which help explain the sleep disorders that can result when sleep transitions go wrong.
021
GLIORESOLVE @glioresolve.bsky.social · 10/11/2025
🚀 Join Dr. Marodon to explore 15 years of innovation in humanized mouse models — from 🧬 T cell repertoire development 🦠 HIV & gene therapy 🎯 Immune checkpoints in cancer 📅 Nov 20, 2025 | 🕓 16:00 CET / 10:00 EST 👉 Register here: lnkd.in/eRm3srWb
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
000
GLIORESOLVE @glioresolve.bsky.social · 07/11/2025
#EXCITINGNEWS Brain Tumor Meeting by the Sea, Second Edition, GOPA/PETRA/ANOCEF, March 23-25 2026, Palais des Congrès, Saint-Malo. #STAY_TUNED Program and registration coming soon.
001
GLIORESOLVE @glioresolve.bsky.social · 07/11/2025
📣 #SAVETHEDATE! - by #PETRANetwork November 24, 1:00-2:15pm, online, Manuel VALIENTE: “Exploiting microenvironment heterogeneity to challenge brain metastases in mice and human”. 📅 Monday, November 24 🕐 1.00 - 2.15pm ➡️ lnkd.in/d5W4ihJT ID: 953 4083 2452 Code: 249157
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
001
GLIORESOLVE @glioresolve.bsky.social · 02/11/2025
1️⃣ Treg Breakthrough: Nobel-Winning Cells Turned Against Brain Tumors 🧠✨ Galvez-Cancino et al. show that depleting Tregs in brain tumor models unleashes innate anti-tumor immunity — enabling antibody-dependent killing and reshaping the tumor microenvironment.
110
Reposted by GLIORESOLVE
PPI Ignite Network Ireland @ppi-ignite-net.bsky.social · 31/10/2025
Listen to reflections from some of the PPI Ignite Network’s Public Advisory Panel (PAB). They reflect on the impact of the work personally and professionally. @hrbireland.bsky.social @researchireland.ie www.youtube.com/watch?v=7rF8...
youtube.com
PAB Impact Video
YouTube video by PPI Ignite Network
023
Reposted by GLIORESOLVE
EANO @eanoassociation.bsky.social · 28/10/2025
🎗️ EANO proudly supports the 2025 International Brain Tumour Awareness Week! Let’s raise awareness, support patients, and promote advancements in research in #NeuroOncology. Together, we can make a difference! #EANO #BrainTumourAwareness #btsm #BrainTumours
053